SLEEP DISTURBANCES IN MAJOR PSYCHIATRIC DISORDERS – PREVALENCE, MECHANISMS AND TREATMENT – A NARRATIVE REVIEW

Sleep disturbances are among the most prevalent and disabling symptoms across major psychiatric disorders, yet they remain underrecognized and undertreated. This review synthesizes findings from 43 peer-reviewed studies published between 2008 and 2025, examining the prevalence, neurobiological mechanisms, and treatment of sleep abnormalities in major depressive disorder (MDD), bipolar disorder (BD), schizophrenia (SCZ), and post-traumatic stress disorder (PTSD). Across disorders, insomnia is the most frequent disturbance, affecting up to 80% of patients with MDD and nearly 90% of those with PTSD. Other recurrent abnormalities include hypersomnia during depressive phases of BD, circadian rhythm misalignment, and fragmented sleep in SCZ. Neurobiological evidence implicates dysregulation of the circadian system, hyperactivity of the hypothalamic–pituitary–adrenal axis, orexin signaling imbalance, and neuroinflammatory processes as shared mechanisms underlying psychiatric sleep pathology. Effective management requires a multimodal approach. Cognitive behavioral therapy for insomnia (CBT-I) demonstrates robust efficacy across disorders, improving both sleep and psychiatric outcomes. Pharmacological interventions—such as dual orexin receptor antagonists, melatonin agonists, and sedating psychotropics—show moderate benefits but require careful monitoring. Chronotherapeutic and neuromodulatory strategies (e.g., light therapy and noninvasive brain stimulation (NIBS) represent promising adjuncts for circadian stabilization. Overall, sleep disturbances emerge as transdiagnostic phenomena that both reflect and exacerbate psychiatric pathology. Early identification and targeted treatment of sleep problems may enhance therapeutic response, reduce relapse risk, and improve overall functioning. Integrating systematic sleep assessment into routine psychiatric care is essential for achieving comprehensive, recovery-oriented treatment.

Authors

Institutions

Publication Details

Journal
International Journal of Innovative Technologies in Social Science
Published
2025-12-29
DOI
https://doi.org/10.31435/ijitss.4(48).2025.4307
Primary Topic
Sleep and Wakefulness Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SLEEP DISTURBANCES IN MAJOR PSYCHIATRIC DISORDERS – PREVALENCE, MECHANISMS AND TREATMENT – A NARRATIVE REVIEW

Paweł Edyko, Katarzyna Andrzejewska, Anna Maria Gęsińska, Hubert Woźniak et al.
International Journal of Innovative Technologies in Social Science
Sleep and Wakefulness Research
article

SLEEP DISTURBANCES IN MAJOR PSYCHIATRIC DISORDERS – PREVALENCE, MECHANISMS AND TREATMENT – A NARRATIVE REVIEW

Paweł Edyko, Katarzyna Andrzejewska, Anna Maria Gęsińska, Hubert Woźniak, Helena Szelka, Zuzanna Przybyła, Krystian Czyżykowski, Alicja Babula, Wiktor Golus, Bartosz Golis
article en

Abstract

Sleep disturbances are among the most prevalent and disabling symptoms across major psychiatric disorders, yet they remain underrecognized and undertreated. This review synthesizes findings from 43 peer-reviewed studies published between 2008 and 2025, examining the prevalence, neurobiological mechanisms, and treatment of sleep abnormalities in major depressive disorder (MDD), bipolar disorder (BD), schizophrenia (SCZ), and post-traumatic stress disorder (PTSD). Across disorders, insomnia is the most frequent disturbance, affecting up to 80% of patients with MDD and nearly 90% of those with PTSD. Other recurrent abnormalities include hypersomnia during depressive phases of BD, circadian rhythm misalignment, and fragmented sleep in SCZ. Neurobiological evidence implicates dysregulation of the circadian system, hyperactivity of the hypothalamic–pituitary–adrenal axis, orexin signaling imbalance, and neuroinflammatory processes as shared mechanisms underlying psychiatric sleep pathology. Effective management requires a multimodal approach. Cognitive behavioral therapy for insomnia (CBT-I) demonstrates robust efficacy across disorders, improving both sleep and psychiatric outcomes. Pharmacological interventions—such as dual orexin receptor antagonists, melatonin agonists, and sedating psychotropics—show moderate benefits but require careful monitoring. Chronotherapeutic and neuromodulatory strategies (e.g., light therapy and noninvasive brain stimulation (NIBS) represent promising adjuncts for circadian stabilization. Overall, sleep disturbances emerge as transdiagnostic phenomena that both reflect and exacerbate psychiatric pathology. Early identification and targeted treatment of sleep problems may enhance therapeutic response, reduce relapse risk, and improve overall functioning. Integrating systematic sleep assessment into routine psychiatric care is essential for achieving comprehensive, recovery-oriented treatment.

International Journal of Innovative Technologies in Social ScienceVol. 3(4(48))
Clinical Hospital No. 8 (RU), Copernicus Memorial Hospital (PL), Antoni Jurasz University Hospital (PL), Medical University of Lodz (PL), Central Clinical Hospital (PL), Wroclaw Research Centre EIT+ (Poland) (PL)
Good health and well-being
Openalex Percentile: Top 30%
Sleep and Wakefulness Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.